DIAGNOSTIC AND PROGNOSTIC VALUE OF INTERLEUKIN-6 AND C-REACTIVE PROTEIN IN COMMUNITY-ACQUIRED PNEUMONIA

被引:90
作者
ORTQVIST, A
HEDLUND, J
WRETLIND, B
CARLSTROM, A
KALIN, M
机构
[1] HUDDINGE HOSP,DIV BACTERIOL,S-14186 HUDDINGE,SWEDEN
[2] DANDERYD HOSP,DEPT CLIN CHEM,S-18288 DANDERYD,SWEDEN
[3] KAROLINSKA INST,KAROLINSKA HOSP,DEPT MED,DIV INFECT DIS,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.3109/00365549509047046
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The diagnostic and prognostic value of admission serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) was investigated in 203 hospital-treated patients with community-acquired pneumonia (CAP). In serum samples obtained during the first 24 h after admission, IL-6 was detectable in 198 patients (98%), with a median value of 50 ng/l. Ten % of the patients had IL-6 values of 1000 ng/l. A clear positive correlation between IL-6 and CRP was found (r = 0.29, p < 0.0001). Patients with high IL-6 or CRP levels had longer duration of fever, longer hospital stay, and had less often recovered clinically or radiographically on follow-up weeks after discharge, A high IL-6, but not a high CRP, also seemed to be associated with a higher mortality. Bacteremic pneumococcal pneumonia had the highest levels of IL-6 (mean 2852 and median 420 ng/l) and CRP (mean 292 and median 285 mg/l). High IL-6 values were also seen in patients with non-bacteremic pneumococcal pneumonia, while all patients with pneumonia due to other bacterial, or viral, aetiology had IL-6 levels of less than or equal to 300 ng/l, In conclusion, IL-6 and CRP are promising diagnostic and prognostic tools in the management of CAP. Further studies are needed to establish the usefulness of repeated measurements early in the hospital course of the disease.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 30 条
[1]   INTERLEUKIN-6 IN CLINICAL MEDICINE [J].
BAUER, J ;
HERRMANN, F .
ANNALS OF HEMATOLOGY, 1991, 62 (06) :203-210
[2]   INTERLEUKIN-6 RESPONSE TO URINARY-TRACT INFECTION IN CHILDHOOD [J].
BENSON, M ;
JODAL, U ;
ANDREASSON, A ;
KARLSSON, A ;
RYDBERG, J ;
SVANBORG, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :612-616
[3]   DIAGNOSIS OF PNEUMONIA BY CULTURES, BACTERIAL AND VIRAL-ANTIGEN DETECTION TESTS, AND SEROLOGY WITH SPECIAL REFERENCE TO ANTIBODIES AGAINST PNEUMOCOCCAL ANTIGENS [J].
BURMAN, LA ;
TROLLFORS, B ;
ANDERSSON, B ;
HENRICHSEN, J ;
JUTO, P ;
KALLINGS, I ;
LAGERGARD, T ;
MOLLBY, R ;
NORRBY, R .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :1087-1093
[4]   PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].
CASEY, LC ;
BALK, RA ;
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778
[5]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[6]   HIGH-LEVELS OF INTERLEUKIN-8 IN THE BLOOD AND ALVEOLAR SPACES OF PATIENTS WITH PNEUMONIA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME [J].
CHOLLETMARTIN, S ;
MONTRAVERS, P ;
GIBERT, C ;
ELBIM, C ;
DESMONTS, JM ;
FAGON, JY ;
GOUGEROTPOCIDALO, MA .
INFECTION AND IMMUNITY, 1993, 61 (11) :4553-4559
[7]   CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY [J].
DAMAS, P ;
LEDOUX, D ;
NYS, M ;
VRINDTS, Y ;
DEGROOTE, D ;
FRANCHIMONT, P ;
LAMY, M .
ANNALS OF SURGERY, 1992, 215 (04) :356-362
[8]   NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES [J].
FANG, GD ;
FINE, M ;
ORLOFF, J ;
ARISUMI, D ;
YU, VL ;
KAPOOR, W ;
GRAYSTON, JT ;
WANG, SP ;
KOHLER, R ;
MUDER, RR ;
YEE, YC ;
RIHS, JD ;
VICKERS, RM .
MEDICINE, 1990, 69 (05) :307-316
[9]   PREDICTING DEATH IN PATIENTS HOSPITALIZED FOR COMMUNITY-ACQUIRED PNEUMONIA [J].
FARR, BM ;
SLOMAN, AJ ;
FISCH, MJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :428-436
[10]  
FINE MJ, 1990, AM J MED, V88